Pricing Log in Create free account
Friday 6 November 2026 Export ATR’s income statement to Excel — free account

AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

139.67 4.37 −3.03%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

AptarGroup, Inc. 10-Q filed Oct 30, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed · accepted 10:00 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors
Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Jul 31, 2026: 9 added · 5 removed · 40 modified; 10 with only figures updated

  1. Added · DECONSOLIDATION OF RUSSIAN SUBSIDIARY

    For all periods presented through September 21, 2026, the operating results of our Russian subsidiary are included in our consolidated financial statements. As of September 21, 2026, we deconsolidated our Russia operations from our consolidated financial statements and recognized a loss on deconsolidation. See Note 20 - Deconsolidation for more information.